Our data suggest that the serum level of IL8 may indicate both intrinsic and acquired chemoresistance and may be a potential marker to evaluate the response to platinum-based chemotherapy in pancreatic cancer. This evidence concerns the gene CXCL8 and pancreatic neoplasm.